Piper Jaffray reiterates an Underweight rating on Accretive Health after the Minnesota Attorney General on Tuesday filed an amendment to the lawsuit against the company with more violations. Piper said it is nervous about the impacts of the lawsuit on Accretive Health's business and keeps an $8 price target for shares.
Asian stocks fell to one-month lows on Friday and the yen rebounded broadly as extreme volatility in the Nikkei …